TITLE

Triflusal: A Viewpoint by F. Pérez Gómez

AUTHOR(S)
Pérez Gómez, F.
PUB. DATE
June 1998
SOURCE
Drugs;Jun1998, Vol. 55 Issue 6, p834
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Comments on the efficacy of triflusal, an antiplatelet drug for heart diseases. Advantages of triflusal over aspirin; Situations in which the risk of bleeding outweighs the benefit of antiplatelet drugs.
ACCESSION #
9593052

 

Related Articles

  • Aspirin for unstable angina? Petch, M.C. // British Medical Journal (Clinical Research Edition);7/5/1986, Vol. 293 Issue 6538, p1 

    Examines the effectiveness of aspirin on unstable angina. Angiographic pattern of coronay artery disease in patients with unstable angina; Occurrence of the disease; Reduction of risk of subsequent cardiac events in patients.

  • Aspirin in Patients with Diabetes Mellitus and CAD. Huffman, Grace Brooke // American Family Physician;4/1/1999, Vol. 59 Issue 7, p1952 

    Focuses on a study conducted by Harpaz and colleagues which evaluated the benefits of aspirins in patients with diabetes mellitus and coronary artery disease. Screening method used by the researchers; Research findings; Conclusion derived by the researchers.

  • Clopidogrel plus aspirin was effective but increased bleeding in acute coronary syndromes without ST-segment elevation. Kronzon, Itzhak; Feit, Frederick // ACP Journal Club;Mar/Apr2002, Vol. 136 Issue 2, p45 

    Presents information on a study which examined the efficacy and safety of early and long-term use of clopidogrel plus aspirin and aspirin alone in patients with acute coronary syndromes without ST-segment elevation. Methodology of the study; Results; Comments on the outcome of the study.

  • Review: Aspirin reduces vascular events but increases bleeding in primary and secondary prevention. Mukherjee, Debabrata; Baigent, C. // ACP Journal Club;9/22/2009, Vol. 151 Issue 3, p2 

    The article presents the findings of a study regarding the benefits and risks of aspirin. Aspirin is stated to reduce vascular events but increases bleeding in primary and secondary prevention. Primary prevention trials included patients who did not have diabetes and were scheduled for 2 years...

  • Does Aspirin Therapy Increase the Risk of Stroke? Walling, Anne D. // American Family Physician;9/1/1999, Vol. 60 Issue 3, p962 

    Presents an abstract of the study `Risk of Primary Intracerebral Hemorrhage Associated With Aspirin and Non-Steroidal Anti-Inflammatory Drugs: Case-Control Study,' by A.G. Thrift et al., published on the March 20, 1999 issue of the `British Medical Journal.'

  • Aspirin for the Primary Prevention of Cardiovascular Events: Recommendation and Rationale.  // Annals of Internal Medicine;1/15/2002, Vol. 136 Issue 2, p157 

    Presents the recommendation of the U.S. Preventive Services Task Force (USPSTF) on the efficacy of aspirin in preventing cardiovascular events. Capability to decrease the incidence of coronary heart diseases; Tendency to increase gastrointestinal bleeding; Suggestion of USPSTF on aspirin therapy.

  • Evidence for aspirin use.  // GP: General Practitioner;8/22/2008, p35 

    The article presents the evidence for aspirin use. It states that aspirin is increasingly being taken by healthy people. Also, people who took aspirin are at unnecessary risk of gastrointestinal hemorrhage. It adds that aspirin still benefits patients with high cardiovascular risk. However, more...

  • Aspirin for all over 50 revisited. Elwood, Peter; Morgan, Gareth // Heart;Nov2008, Vol. 94 Issue 11, p1364 

    The article reports on a study of the risks of aspirin prophylaxis among diabetic patients with ages ranging between 30 to 74 years. It states that vascular risk of aspirin prophylaxis is estimated to people whose age is 48 years old for men and 57 years old for women. It also mentions that...

  • Aspirin for stroke and heart disease.  // American Family Physician;12/1/1995, Vol. 52 Issue 8, p2373 

    Reports on a study on the effectiveness of aspirin therapy in the prevention of coronary and cerebrovascular disease in patients in Great Britain, as presented in the July 1995 issue of `The Practitioner.' Finding that doses of at least 75 milligrams of aspirin per day reduces the risk of...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics